Previous studies found that CD47, a transmembrane glycoprotein, is present in a variety of cells, that its expression is significantly increased in tumor cells (Hu et al., 2021), and there is also some increased expression in normal ADMSCs. The gene discussed is CD47; the disease is neoplasm.